SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Rite Aid Corporation (RAD)
NEW YORK, NY / ACCESSWIRE / November 8, 2018 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/rad.
The investigation concerns whether Rite Aid and certain of its officers and/or directors have issued materially misleading business information to the investing public, specifically regarding the level of regulatory risk faced by the Original Merger and the Revised Merger.
On October 27, 2015, Rite Aid and Walgreens Boots Alliance, Inc. ("Walgreens") revealed an Agreement and Plan of Merger (the "Original Merger Agreement"). Under the terms of the Original Merger Agreement, Walgreens would acquire Rite Aid for $9.00 per share. On January 30, 2017, Rite Aid and Walgreens stated that they had entered into a new merger agreement (the "Revised Merger Agreement"), pursuant to which Rite Aid stockholders would now receive between $6.50 to $7.00 per share. Then on June 29, 2017, Rite Aid and Walgreens revealed that they had terminated the Revised Merger Agreement.
If you are aware of any facts relating to this investigation, or purchased shares of Rite Aid, you can assist this investigation by visiting the firm's site: bgandg.com/rad. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
